Synthetic Biology-Based Point-of-Care Diagnostics for Infectious Disease.
Infectious diseases outpace all other causes of death in low-income countries, posing global health risks, laying stress on healthcare systems and societies, and taking an avoidable human toll. One solution to this crisis is early diagnosis of infectious disease, which represents a powerful way to optimize treatment, increase patient survival rate, and decrease healthcare costs. However, conventional early diagnosis methods take a long time to generate results, lack accuracy, and are known to seriously underperform with regard to fungal and viral infections. Synthetic biology offers a fast and highly accurate alternative to conventional infectious disease diagnosis. In this review, we outline obstacles to infectious disease diagnostics and discuss two emerging alternatives: synthetic viral diagnostic systems and biosensors. We argue that these synthetic biology-based approaches may overcome diagnostic obstacles in infectious disease and improve health outcomes.
Interdisciplinary Program of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.
Ting-Yen
TY
Wei
Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 300, Taiwan. Electronic address: chaomin@mx.nthu.edu.tw.
Chao-Min
CM
Cheng
D003141:Communicable Diseases / Q000175:diagnosis*; D006801:Humans; D019095:Point-of-Care Systems; D058615:Synthetic Biology